• Gastrin I: Precision Tools for Gastric Acid Secretion Pathwa

  2026-07-12

  Human Gastrin I peptide enables high-fidelity modeling of gastric acid secretion and CCK2 receptor signaling in advanced in vitro systems. Integrating organoid workflows and quantitative assay parameters, this guide empowers researchers to troubleshoot, optimize, and accelerate gastrointestinal disorder research using APExBIO's rigorously validated reagent.

• Lopinavir (ABT-378): Mechanistic Rationale and Translational

  2026-07-10

  This article explores the mechanistic underpinnings and strategic value of Lopinavir (ABT-378) for translational HIV research, resistance profiling, and cross-pathogen antiviral development. Emphasizing protocol nuances and competitive context, it guides researchers seeking to bridge basic enzymology with clinically relevant antiviral strategies.

• Hesperadin: Applied Aurora B Kinase Inhibition in Cell Cycle

  2026-07-09

  Hesperadin is a precision ATP-competitive Aurora B kinase inhibitor, unlocking advanced control over mitotic progression and spindle assembly checkpoint disruption in cell-based assays. This article delivers stepwise protocols, troubleshooting strategies, and insight into leveraging Hesperadin for high-impact cancer and cell cycle studies.

• Force-Driven Multimotor Transport of Lipid Droplets in Tunne

  2026-07-09

  This study introduces a quantitative framework for understanding how force-regulated multimotor coordination governs the bidirectional transport of lipid droplets through tunneling nanotubes. By integrating optical tweezers and confocal microscopy, the authors reveal unique mechanical features of organelle transfer in confined intercellular structures, providing insights relevant for advanced live-cell imaging and mechanistic cell biology.

• Cefiderocol Activity Against Resistant P. aeruginosa and Aci

  2026-07-08

  This large-scale European study systematically compared cefiderocol against a range of β-lactam/β-lactamase inhibitor combinations for multidrug-resistant Pseudomonas aeruginosa and Acinetobacter spp. isolates. The findings demonstrate cefiderocol’s superior in vitro efficacy, particularly against carbapenem- and inhibitor-resistant strains, and offer significant methodological insights for antimicrobial resistance research.

• Methicillin Sodium Salt: Optimizing Gram-Positive Infection

  2026-07-08

  Methicillin sodium salt empowers researchers to model Staphylococcus aureus infections with precision, offering reproducible outcomes in susceptibility and cell viability assays. This article translates bench research into actionable guidance, including advanced workflow steps, troubleshooting, and practical protocol improvements to maximize methicillin’s value in MSSA-focused studies.

• Latrunculin B: Precision Disruption of Actin for Mechanistic

  2026-07-07

  Explore how Latrunculin B enables targeted actin cytoskeleton disruption for next-generation cellular research. This in-depth guide uses recent evidence to clarify Latrunculin B’s true specificity, assay limitations, and strategic role compared to alternative inhibitors.

• SM-164: Bivalent Smac Mimetic for Precision Apoptosis Induct

  2026-07-07

  SM-164 is a next-generation bivalent Smac mimetic that enables rapid, TNFα-dependent apoptosis in diverse cancer models by targeting IAPs with high specificity. This article guides researchers through optimized workflows, troubleshooting solutions, and mechanistic insights to fully leverage SM-164’s unique properties in advanced cancer research applications.

• Erlotinib (NSC 718781): Precision EGFR Inhibition in Cancer

  2026-07-06

  Erlotinib empowers researchers to dissect EGFR-driven oncogenic pathways with high sensitivity and reproducibility, especially in models where resistance and immune evasion complicate outcomes. This guide details optimized workflows, advanced applications, and troubleshooting strategies for leveraging Erlotinib (NSC 718781) from APExBIO in translational cancer research.

• Palomid 529 (P529): Advancing PI3K/Akt/mTOR Inhibition in Tr

  2026-07-06

  Explore how Palomid 529 (P529) uniquely enables translational research targeting the PI3K/Akt/mTOR pathway, with applications from tumor angiogenesis inhibition to radiotherapy enhancement. This article delivers a deeper mechanistic and application guide for advanced cancer and neuroscience research.

• Methicillin Sodium Salt: Precision Tools for MSSA Research

  2026-07-05

  Methicillin sodium salt from APExBIO offers unparalleled reliability for modeling Staphylococcus aureus infections and benchmarking antibiotic susceptibility in gram-positive bacteria. This guide translates advanced screening insights into actionable laboratory workflows, with troubleshooting strategies that ensure robust, reproducible results for infection research.

• 1-methyl Adenosine: Optimizing RNA Modification Research Wor

  2026-07-04

  1-methyl Adenosine (1-methyl Ado) is a cornerstone of advanced RNA modification research and cancer metabolism studies, enabling robust quantification and mechanistic insights. This article details actionable protocols, troubleshooting strategies, and new analytical innovations that maximize the impact of 1-methyl Ado in biomarker discovery and therapeutic target validation workflows.

• ATS-9R: Transforming Adipose Tissue Gene Silencing Strategie

  2026-07-03

  Discover how ATS-9R (Adipocyte-targeting sequence-9-arginine) enables precise, non-viral gene delivery to adipose tissue, unlocking advanced research in metabolic disease and inflammation. This article provides a unique, application-focused perspective with actionable assay guidance.

• EZ Cap™ Cas9 mRNA (m1Ψ): Boosting Editing Precision and Effi

  2026-07-03

  EZ Cap™ Cas9 mRNA (m1Ψ) sets a new standard for CRISPR genome editing, combining Cap1 capping, m1Ψ modification, and poly(A) tailing for superior stability and translation in mammalian cells. This advanced mRNA solution from APExBIO empowers researchers to achieve high-efficiency, low-immunogenicity editing, while integrating seamlessly with the latest specificity control strategies.

• WP1066, JAK2/STAT3 Inhibitor: Advanced Cancer & Regeneration

  2026-07-02

  WP1066, a potent cell-permeable JAK2/STAT3 inhibitor, enables precise modulation of cancer signaling pathways and macrophage immunometabolism. This guide bridges advanced protocol design, troubleshooting, and translational applications in oncology and bone repair.

441 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page